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Many epithelial stem cell populations follow a pattern of stochastic stem cell divisions called
'neutral drift'. It is hypothesised that neutral competition between stem cells protects against
the acquisition of deleterious mutations. Here we use a Porcupine inhibitor to reduce Wnt
secretion at a dose where intestinal homoeostasis is maintained despite a reduction of Lgr5+
stem cells. Functionally, there is a marked acceleration in monoclonal conversion, so that
crypts become rapidly derived from a single stem cell. Stem cells located further from the
base are lost and the pool of competing stem cells is reduced. We tested whether this loss of
stem cell competition would modify tumorigenesis. Reduction of Wnt ligand secretion
accelerates ﬁxation of Apc-deﬁcient cells within the crypt leading to accelerated tumor-
igenesis. Therefore, ligand-based Wnt signalling inﬂuences the number of stem cells, ﬁxation
speed of Apc mutations and the speed and likelihood of adenoma formation.
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The intestinal epithelium is constantly renewing and newepithelial cells are continuously produced by a smallnumber of intestinal stem cells (ISCs) located at the base of
the crypt1, 2. These crypt columnar stem cells exhibit the highest
levels of Wnt signalling demonstrated by nuclear β-catenin
staining and high expression of a number of Wnt target genes
including Lgr5. The expression of Lgr5 within these cells ampliﬁes
Wnt ligand signalling as R-spondin binds to the LGR5 receptor to
agonise Wnt signalling3. Wnt ligands are produced by the epi-
thelium (Wnt3 from the Paneth cells) and the mesenchyme4,
which also produces R-spondin. Although excellent evidence
exists showing that Lgr5+ cells can act as functional stem cells in
the adult intestinal epithelium, these cells are dispensable for
homoeostasis (over the measured time period of 10 days), though
they are required for regeneration post irradiation5, 6.
Over recent years it has been accepted that these Lgr5 ISCs are
not long lived but rather replace each other in a stochastic fashion
termed 'neutral drift'. Functionally, the progeny of one stem cell
displaces all other stem cells from the niche and becomes ﬁxed in
the crypt7, 8. This stochastic replacement also explains stem cell
dynamics in other proliferating tissues like skin or during
spermatogenesis9.
Through this process it is hypothesised that cells that have
acquired deleterious mutations would be likely displaced by their
neighbouring wild-type ISCs. In vivo imaging studies have
monitored this competition in real time. These studies have
shown that stem cells at border regions (higher up from the base
of the crypt) can be pushed into the transit amplifying zone of the
crypt, while stem cells at the centre/base of the crypt are more
likely to be retained. Importantly border stem cells can also return
to the centre position and regain functional stem cell properties1.
The Wnt signalling pathway has been shown to be required for
intestinal homoeostasis. Genetic loss of the Wnt transcription
factor Tcf4/β-catenin or suppression of Wnt ligand-based sig-
nalling via Dkk overexpression led to rapid loss of small intestinal
crypts10–12. Additionally, R-spondins are essential for ISCs and
crypt maintenance, since complete inhibition by blocking their
Lgr5 and Znrf3/Rnf43 binding domains results in crypt death.
However, inhibition of only one of the binding domains results in
a reduced number of Lgr5+ cells but otherwise normal crypt
homoeostasis. This reduction in Lgr5+ cells resulted in a rapid
ﬁxation of the remaining ISCs in the crypt13.
This model where stem cells compete with each other has also
been applied to examine oncogenic events that might confer
advantages to ISCs carrying that mutation. Common mutations
in CRC (KrasG12D mutation and Apc deletion) have been targeted
to ISCs in the mouse and have been shown to inﬂuence the
neutral drift. In both cases there was a greater chance for these
mutated stem cells to replace other wild-type cells in the
crypt14, 15.
One technical caveat to these studies is the methodology used
to mark crypts in the mouse and determine ISC dynamics. The
studies comparing the advantages of a speciﬁc mutation relied on
cre-mediated expression of KRASG12D mutation or Apc gene
deletion within ISCs. Tracking of mutant clones were all per-
formed using a reporter gene from the Rosa26 promoter (e.g.
Rosa26-Lox-Stop-Lox-tdTomato) allele rather than assaying
recombination at the Kras or Apc locus itself. Importantly pre-
vious studies have suggested there may be discordance between
reporter alleles16; therefore, there is a possibility that the precise
rates of advantages of these alleles may be different if there are
clones that fail to recombine the gene of interest and only the
reporter gene (and vice versa). Moreover, it is important to realise
that even if mutations are non-neutral, these mutations are not
deterministic: mutated stem cells are still surrounded by non-
mutated stem cells and therefore have a high chance to be
replaced by wild-type cells.
Instead of complete inhibition, reduction of Wnt signalling by
Wnt ligand inhibitors in adult mice and humans has shown that
these inhibitors can be well tolerated, though do result in dra-
matically fewer stem cells17. Here we have used a Porcupine
inhibitor to reduce Wnt secretion and test the consequences of
lowering the number of functional stem cells per crypt and its
effect on stem cell competition. We ﬁnd that crypts are rapidly
derived from a single stem cell and using in vivo imaging we show
the reason for this is that stem cells at border regions are rapidly
lost. To test the functional relevance of this reduction of stem cell
competition for tumorigenesis, we examined whether this would
accelerate the ﬁxation of Apc-deﬁcient cells in the intestine.
Importantly, we discovered that the widely used R26tdTomato
reporter poorly reports efﬁcient recombination of the two Apc
alleles in vivo. Using RNA in situ and immunohistochemistry to
report loss of Apc we show that reduction of Wnt ligands results
in more efﬁcient tumorigenesis due to the rapid ﬁxation of Apc-
deﬁcient crypts.
Together our data suggest neutral drift and stem cell compe-
tition require an optimal level of ligand driven Wnt signalling
that has evolved to allow the rapid loss of deleterious mutation
but also to protect against the acquisition of advantageous
tumour-promoting mutations.
Results
Wnt inhibition only has minor effects on homoeostasis. We
assessed intestinal homoeostasis after treatment with a Porcupine
inhibitor LGK974, otherwise known as WNT97417. Consistent
with previous studies targeting Porcupine and other strategies to
dampen Wnt ligand-based signalling18, reduction of Wnt ligand
secretion did not change rates of crypt proliferation (Fig. 1a, b).
Although the total number of proliferating cells per crypt did not
change, there was a small yet signiﬁcant alteration in the dis-
tribution of the proliferative cells. Following porcupine treatment
all the proliferative cells are found lower in the crypt compared to
the vehicle/untreated mice (Supplementary Figure 1). The most
striking impact of Wnt inhibition was the marked down-
regulation of several ISC genes, e.g. Lgr5, Olfm4 and Lrig1
(Fig. 1a, c). Interestingly, there was no change in Bmi1 expression
(Fig. 1c). We performed RNA sequencing from whole intestine to
analyse the effect of reduced Wnt signalling on global gene
expression (Supplementary Figure 2a and Supplementary Data 1),
which revealed only a small number of signiﬁcantly deregulated
genes (22 upregulated, 44 downregulated). Among the down-
regulated genes was the canonical Wnt target gene Axin2, and the
ISC genes Olfm4 and CD133. We observed a reduced number of
Paneth cells only after long-term treatment (~30 days), which
indicates the requirement of Wnt ligands for the generation of
new Paneth cells (Supplementary Figure 2b).
Given this relatively mild effect on homoeostasis we wanted to
test if intestinal regeneration following irradiation was affected as
this is a Wnt regulated process and requires Lgr5+ cells11, 19. We
observed an inhibition of intestinal regeneration after irradiation
(Supplementary Figure 2c) consistent with previous studies18. We
also investigated whether Porcupine inhibition could suppress
hyperproliferation and increase crypt number induced by
oncogenic mutations (either BrafV600E/+ or BrafV600E/+ Ptenﬂ/ﬂ)
and again saw a marked impact on these phenotypes (Supple-
mentary Figure 3). Finally given the previous genetic studies
showing that complete Wnt ligand inhibition caused the loss of
crypts12, we examined if Porcupine inhibition in combination
with reduced β-catenin levels might disrupt tissue homoeostasis.
The Porcupine inhibitor at the used dosage is well tolerated and
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Fig. 1 Homoeostasis is unperturbed after LGK974 treatment. a C57BL/6 mice were treated with LGK974 for 4.5 days. The small intestine showed no
toxicity and no difference in proliferation (BrdU). Treatment of LGK974 leads to downregulation of the intestinal stem cell genes Lgr5 and Olfm4 as
conﬁrmed by RNA in situ hybridisation. Note only a few cells at the bottom of the crypt still express Olfm4 after LGK974 treatment (N= 3 for both groups).
b Quantiﬁcation of BrdU+ cells/half-crypt (at least 30 crypts per mouse were analysed). Each dot represents the average per mouse, red bar=mean per
group. Vehicle (VEH) N= 3, LGK974 (LGK) N= 4. c qRT-PCR conﬁrms downregulation of several stem cell genes, whereas expression of Bmi1 is
unchanged. Each dot represents single mouse sample, black bar indicates mean per group, N= 3 per group. d Uninduced Catnblox(ex3)/lox(ex3) are
hypomorphs with about 50% reduced expression of β-catenin (Ctnnb1), as conﬁrmed by qRT-PCR (N= 3). e Reduced expression of β-catenin results in
hyper-sensitivity to LGK974 and loss of the (small) intestinal crypts within 10 days (mean survival), N= 8. Scale bar= 50 µm
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mice can be treated for several weeks. Mice with reduced
expression of β-catenin are viable and display no phenotype
throughout their life. However, a reduction of β-catenin
expression by 50% renders these mice sensitive to the Porcupine
inhibitor and resulted in rapid crypt loss within 8–12 days
(Fig. 1d, e). Together these data highlight that the intestinal
epithelium can tolerate a reduction in Wnt ligand signalling but
further reduction of β-catenin causes a complete loss of crypts.
This is consistent with previous work using higher doses of
Porcupine inhibitors17, 18.
Reduced Wnt ligand secretion decreases crypt ﬁxation time.
Given the very selective effect of Wnt ligand reduction via Por-
cupine inhibition upon Lgr5 and other ISC genes, we wanted to
assess the impact this had upon ISC dynamics. To do this we used
well-established techniques examining the ability of single stem
cells (labelled by tomato) to repopulate entire crypts.
This was achieved using the Lgr5-EGFP-CreER (Lgr5CreER)
mouse crossed to the R26R-LoxStopLox-tdTomato (tdTomﬂ)
mouse. Induction with a previously established low tamoxifen
concentration resulted in recombination of very few Lgr5+ cells
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Fig. 2 Stem cell replacement rate is accelerated after LGK974 treatment. Mice were induced with 0.15 mg tamoxifen to induce tdTomﬂ recombination in
few Lgr5-CreER-EGFP+ cells. a Mosaic expression of the Lgr5-eGFP (green) and the recombined tdTomﬂ+ cells (red). Nuclei were stained with DAPI
(blue). Representative pictures at day 10, note the loss of GFP expression and clones are fully labelled by tdTom+ cells in Porcupine inhibitor-treated mice
(LGK974). Scale bar= 100 um. b Clone size was counted in 'eighths', at time indicated after induction. At least 200 clones per mouse were counted,
vehicle (VEH) N= 3, 3, 4, 4, 3, 3 and LGK974 (LGK) N= 2, 4, 3, 5, 3, 3 for each timepoint, respectively. Heatmap shows all counted clones per timepoint/
group. Note that LGK974 has an increased clone size at day 4 and the mean clone size from day 7 is almost at its maximum. Graph shows the mean clone
size (c) or the number of fully ﬁxed crypts (d) at different time points as shown in b. Error bars, s.e.m. e Number of tdTom+ clones per ﬁeld. The number of
crypts with at least one tdTom+ cell were counted per ﬁeld, ≥19 images per mouse, error bars= s.e.m. Note the similar number of clones at day 4 but the
greater reduction in clones after LGK974 treatment at day 10. Vehicle (VEH) N= 3, 3, 4, 4, 3, 3 and LGK974 (LGK) N= 2, 4, 3, 5, 3, 3 for each timepoint
respectively
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per crypt which are then permanently labelled by expression of
the tdTom reporter. The fate of these stem cells can be monitored
to see if they are lost or take over the full crypt. Lgr5CreER tdTomﬂ
mice were induced and treated from 24 h post induction with
either LGK974 or vehicle. After treatment with LGK974 we
observed a reduction in the Lgr5-GFP signal consistent with our
previous qRT-PCR and ISH data (Fig. 2a). Importantly, we saw a
dramatic increase in the average clone size after administration of
the Porcupine inhibitor. This was observable 4 days
post induction and further increased during the time course
(Fig. 2b, c). This resulted in a striking increase in the number of
fully ﬁxed clones (Fig. 2d), with more than 80% of crypts fully
ﬁxed after 3 weeks (<20% in the vehicle control), a process which
usually takes about 2–4 months7, 8. The competition between
labelled and unlabelled cells within a crypt resulted in many
crypts losing the tdTom label, in accordance with neutral drift.
The vehicle treatment resulted in a progressive decline in the
number of tdTom+ crypts, whereas treatment with LGK974
accelerated this process and the ﬁnal number of tdTom+ crypts
was reached after 10 days (Fig. 2e). This analysis also conﬁrmed
that an equal number of crypts were recombined before the start
of the treatment (Fig. 2e, day 4). To investigate clonal dynamics
using a system that is not limited to recombination in only Lgr5-
positive stem cells, we repeated this experiment using another
inducible cre (AhCreER, not driven by Lgr5), which has previously
been used for stem cell dynamic studies14. Using an established
low dose induction of AhCreER mice, crossed to the Rosa26
tdTomﬂ mice, we observed a similar increase in the average clone
size after LGK974 treatment compared to vehicle treatment
10 days after induction (Supplementary Figure 4a).
Border stem cells are lost after reduction of Wnt ligand
secretion. The dramatic increase in clone size at early time points
following Porcupine inhibitor treatment gave us an excellent
opportunity to image the Lgr5CreER tdTomﬂ mice in vivo to
elucidate why the stem cell dynamics were altered. The in situ
hybridisation analysis for Lgr5 and Olfm4 showed that there is a
reduction in the expression of these ISC markers. These data
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Fig. 3 In vivo live imaging shows speciﬁc loss of border stem cells after LGK974 treatment. a Graphical representation of the experimental setup. One day
before LGK974 treatment, Lgr5CreER tdTomﬂ mice were injected with 0.05mg tamoxifen IP to induce recombination in single cells. Mice (N= 4) were
treated with LGK974 and daily intravital imaging was performed starting 1 day after ﬁrst LGK974 treatment and compared to control mice (N= 5). b Graph
shows mean clone size (43 crypts, control; 56 crypts, LGK974 on day 1) of surviving clones (clones with at least one cell in centre or border) over time
within the centre and border. Note that cells in the transit amplifying (TA) cell region are not counted. c, e Intravital images of the same crypt on days 1–4
following a clone starting in the centre (c) and a clone starting in the border (e). d, f Graphs show the percentage of clones that still have at least one cell in
the centre or border starting from centre cell (17 crypts, control; 36 crypts, LGK974) (d) or from border cell (26 crypts, control; 20 crypts, LGK974) (f).
Error bars= s.e.m. Scale bar, 20 µm
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treated with LGK974 starting the following day. Mice were sampled at day 4 post induction, and proliferation assessed by BrdU staining. Scale bar= 50
µm. b Lgr5CreER Apcﬂ/ﬂ mice induced with 0.15 mg tamoxifen and treated with LGK974/vehicle 1 day p.i. The number of macroscopic adenomas was scored
when mice showed signs of intestinal adenomas or at 100/130 day timepoint. Each dot represents one mouse, untreated N= 5, vehicle N= 7 and LGK974
N= 9, black dot=mean, error bars= s.e.m., Mann–Whitney U test: untreated vs. LGK974 p= 0.002639, vehicle vs. LGK974 p= 0.0006014. c
Immunohistochemistry for β-catenin showed only small microadenomas in the vehicle group, in contrast to adenomas found after LGK974 treatment. Scale
bar= 100 µm. d Example image of Lgr5CreER Apcﬂ/ﬂ tdTomﬂ/+ mouse 10 days post induction (3 mg, LGK974 treatment). Immunohistochemistry for
tdTomato (RFP) shows fully labelled crypt. Arrow marks unlabelled cell (probably Paneth cell), suggesting a newly labelled crypt. RNA in situ for Apc exon
14 shows that only half of the crypt has recombined (dashed area). Scale bar= 50 µm. e Lgr5CreER Apcﬂ/ﬂ mice were induced with 3 mg tamoxifen and
treated with LGK974/vehicle starting at day 1 p.i. Crypts were scored based on immunohistochemistry for β-catenin and categorised into partial and full
crypts. The ratio of full crypts is in relation to the sum of full and partial crypts. f Scoring of partial and full crypts at different timpoints in absolute numbers.
N= 3 mice for each timepoint and each group, error bars= s.e.m. g Lgr5CreER Apcﬂ/ﬂ mice induced with 3 mg tamoxifen were treated with LGK974 or
vehicle starting at day 1 p.i. Mice were sampled when signs of intestinal tumour burden were apparent. Untreated N= 5, vehicle (VEH) N= 7, LGK974 N=
9 mice, log-rank test: vehicle vs. LGK974 p= 0.00019, untreated vs. LGK974 p= 0.0222. h Number of adenomas scored on histological sections.
Untreated N= 5, vehicle (VEH) N= 6, LGK974 N= 9 mice. Each dot represents number of lesions per mouse; box indicates mean ± standard deviation.
Mann–Whitney U test for LGK974 vs. control mice (untreated and vehicle) p= 0.02496
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imply that either ISCs reduce expression of these genes, while still
participating in the competition, or that there is a decrease in the
number of functional stem cells per crypt.
To investigate this, we tracked the fate of single Lgr5+ cells via
multiphoton intravital microscopy through an abdominal ima-
ging window1. The Lgr5CreER tdTomﬂ mice were induced with a
low dose of tamoxifen and tdTom+ clones were followed over a
period of 4 days (Fig. 3a). On average, an increase of clonal
progeny (tdTom+) derived from the Lgr5+ cells was observed in
both treatment groups with similar kinetics (Fig. 3b). It has been
previously established that the fate of individual stem cells is
determined by its position in the crypt. Depending on the
position, Lgr5+ cells can be grouped as 'border stem cells' at the
upper part of the stem cell niche and 'centre stem cells' positioned
at the bottom of the crypt1. Despite loss of Lgr5-GFP expression
after LGK974 treatment, originally labelled centre stem cells
persisted at the centre and proliferated similar to the control cells
(Fig. 3c, d). In contrast, following the fate of labelled clones at the
border of the stem cell niche, we observed a reduction in the
number of tdTom+ clones that remained after treatment with
LGK974 (Fig. 3e, f). This suggests that reduction of Wnt ligand
secretion leads to speciﬁc loss of stem cell activity at the upper
part of the stem cell niche. The cells at the bottom of the crypt
show no difference in clonal growth, despite downregulation of
the ISC gene Lgr5. Thus, Wnt ligand inhibition is reducing the
number of stem cells in the niche. Due to the resulting decreased
competition, cells at the centre have a higher chance of
repopulating the crypt quickly when compared with vehicle or
untreated mice.
Reduced stem cell pool facilitates adenoma formation. The
neutral drift of the ISCs is deﬁned by two parameters, the number
of stem cells and the stem cell replacement rate14. We observed
that reduction of Wnt ligand secretion led to a reduction in the
number of stem cells, namely the border stem cells, but otherwise
normal kinetics of the centre stem cells. This is accompanied by
an acceleration of single clones to become ﬁxed. We next
examined if these changes have consequences for tumour
initiation.
Colorectal cancer is characterised by loss of the tumour
suppressor gene APC and our previous studies have shown that
this is sufﬁcient to result in Wnt deregulation and adenoma
initiation in vivo20. Importantly, organoid cultures from Apc-
deﬁcient cells grow as spheres and do not require R-Spondin,
suggesting they are independent of Wnt ligand21. We tested if
Apc-deﬁcient cells are truly independent of secreted Wnt ligands
in vivo. VillinCreER APCﬂ/ﬂ mice were induced and treated with
either vehicle or LGK974. As expected, we saw no impact of the
crypt progenitor phenotype after LGK974 treatment, with marked
hyperproliferation in both vehicle and LGK974-treated mice
(Fig. 4a, Supplementary Figure 4b).
It has been reported that certain mutations (e.g. KrasG12D/+ or
Apc−/+) impart an advantage on ISCs when compared with their
neighbouring wild-type stem cells. This advantage is reﬂected in
an increased probability for a mutant stem cell to replace its
neighbour and ultimately become ﬁxed so that all cells in the
crypt derive from the same mutant clone14, 15. Our data suggest
that a reduction of the stem cell pool also led to a dramatic
acceleration in the time it takes for crypts to become monoclonal.
This leads to the prediction that LGK974 might accelerate the rate
of adenoma initiation through altering stem cell dynamics,
despite not having an impact on Apc-deﬁcient cells.
Previous studies have assumed an equivalent level of
recombination between the R26R-LSL-tdTomato and the gene
of interest. However in our experience we only obtain a robust
tumorigenic phenotype in Lgr5CreER Apcﬂ/ﬂ mice with a single
injection of high concentration tamoxifen22 (≥2 mg tamoxifen,
Supplementary Figure 4c). We therefore ﬁrst decided to test
whether LGK974 could lead to tumour formation following low-
level deletion (0.15 mg) in Lgr5CreER Apcﬂ/ﬂ. Mice were induced
with the low-level tamoxifen and treated 24 h after induction,
which assures recombination of the same number of cells before
treatment. We observed that LGK974 treatment resulted in a
number of macroscopic adenomas, whereas none of the vehicle or
untreated mice had any visible adenomas (Fig. 4b). We then
examined if microscopically there were more lesions on the
intestines dissected from these mice. These can be visualised by
immunohistochemistry for β-catenin (as Apc is deleted).
Histological analysis of an intestinal 'swiss roll' showed that the
majority of vehicle and untreated mice had no lesions (3/5 and 4/
7, respectively) with the other mice containing only a single
microadenoma. In contrast, almost all the LGK974-treated mice
had several adenomas per section (6/7 mice, Fig. 4c). These data
suggest that Porcupine inhibition does affect tumorigenesis in this
murine model of colorectal cancer.
However, the low number of histological lesions in the control
mice did not match the high number of recombined tdTom+
crypts, we would expect based on our clonal analysis with the
same low tamoxifen induction (Fig. 2e). We thought of two
possibilities that could explain this discrepancy: 1. both copies of
Apc are deleted in a large number of crypts, but only few of them
accumulate β-catenin and progress to adenoma formation; 2. that
loss of Apc was occurring at a much lower frequency than the
tdTom reporter would suggest.
To test the latter possibility, we utilised the latest in situ
hybridisation technology 'Basescope'. This technology allows
accurate detection of RNA transcripts by use of short RNA
detection probes. We designed probes that enabled the detection
of exon 14 (117 bp) of Apc, which is deleted following
recombination. We conﬁrmed the speciﬁcity of the RNA in situ
probes on established adenomas from Lgr5CreER Apcﬂ/ﬂ mice,
both for the unrecombined and the recombined Apc allele
(Supplementary Figure 5a, b). Using these probes, we examined
the level of Apc deletion after a single injection of high
concentration tamoxifen (3 mg Lgr5CreER Apcﬂ/ﬂ). Surprisingly
we found very few crypts that had recombined Apc, despite being
positive for the tdTom reporter (Supplementary Figure 5c). This
is not due to leakiness of the reporter since we observed crypts
which had partially recombined for Apc, whereas almost the
entire crypt is positive for tdTom apart from the Paneth cells
which have a longer turnover time (Fig. 4d).
The asynchronous expression of the tdTom reporter and loss
of Apc also holds true with a lower induction of 0.15 mg
tamoxifen in Lgr5CreER Apcﬂ/ﬂ and with a similar low-level
induction in AhCreER Apcﬂ/ﬂ mice (Supplementary Figure 5d).
Furthermore, serial sections revealed that if the Apc gene is lost,
this coincides with accumulation of nuclear β-catenin in the Apc-
deﬁcient cells (Supplementary Figure 5e).
To analyse the stem cell dynamics of Apc-deﬁcient cells
without use of the tdTom reporter, we analysed Lgr5CreER Apcﬂ/ﬂ
mice using a higher concentration of tamoxifen induction (3 mg)
by immunohistochemistry for β-catenin. We could differentiate
between partially recombined crypts and fully recombined crypts
(Fig. 4e), thus allowing us to perform a similar analysis on stem
cell dynamics using nuclear β-catenin as a surrogate.
The ﬁrst detection of nuclear β-catenin+ cell clones was
between 4 and 7 days. We observed a shift towards fully
recombined crypts from day 4 to day 21 in vehicle-treated mice,
suggesting that the β-catenin+ clones replace the WT stem cells
and become ﬁxed in the crypt. This shift is accelerated after
LGK974 treatment, where at day 7 most of the crypts are fully
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populated by β-catenin+ clones (Fig. 4e, f). This conﬁrms our
observation in wild-type mice that treatment with the Porcupine
inhibitor accelerates the stem cell dynamics. The reduction in
partially populated crypts could either result in a fully populated
crypt or the removal of these clones from the crypt. Interestingly,
when treated with the Porcupine inhibitor, crypts appeared to be
fully clonal by day 7—resulting in loss of partial crypts while the
number of full crypts remained comparable from day 7 through
day 21 (Fig. 4f).
The accelerated ﬁxation time of Apc-deﬁcient crypts was
conﬁrmed when we aged Lgr5CreER Apcﬂ/ﬂ mice induced with 3
mg of tamoxifen and treated with Porcupine inhibitor. Here, we
observed a dramatic decrease in the time to intestinal tumorigen-
esis (Fig. 4g). Histological analysis revealed that these mice had
numerous intestinal adenomas (Fig. 4h). Interestingly, we
observed many lesions in the proximal small intestine, whereas
the majority of lesions in control mice were conﬁned to the distal
part of the small intestine (Supplementary Figure 6a). This
tumour distribution is also reﬂected in the ratio of Apc deletion.
Whereas the tdTom reporter would suggest a higher number of
recombined crypts in the proximal compared with the distal small
intestine (Supplementary Figure 6b), we observed the opposite in
terms of Apc deletion. Analysis of several mice revealed that about
70% of the tdTom+ crypts still expressed Apc based on the RNA
in situ probe signal in the proximal small intestine (duodenum).
Only a small fraction of crypts (<5%) were positive for the
tdTom reporter and had lost Apc exon 14 expression in the
majority of cells. In the distal part (ileum) we observed a higher
fraction of tdTom+ cells that had also lost Apc (>20%)
(Supplementary Figure 6c). This correlates with the high number
of adenomas in the distal small intestine compared to the
proximal part.
To show that our ﬁnding is not simply a reﬂection of the
Lgr5CreER-mediated deletion we treated VilCre Apcﬂ/+ mice with
the Porcupine inhibitor, similarly induced with a low concentra-
tion of tamoxifen. Again, we observed a decreased survival of
treated mice, whereas control mice showed no signs of intestinal
adenoma burden within 100 days p.i (Supplementary Figure 7a).
We saw a high frequency of adenomas within the proximal small
intestine, whereas no macroscopic adenomas were found in
control mice (Supplementary Figure 7b). Microscopic analysis
revealed that control mice only had few small lesions, compared
to numerous adenomas in mice after treatment with LGK974
(Supplementary Figure 7c).
Discussion
In summary, we show that the number of ISCs is regulated
by secreted Wnt ligands. Reduction of Wnt ligand secretion
reduced the stem cell pool and led to a faster ﬁxation of a
single ISC clone, probably due to reduced competition for the
stem cell niche (Supplementary Figure 8). Despite down-
regulation of several stem cell genes (e.g. Lgr5), the cells at the
centre of the crypt are functional stem cells and maintain
intestinal homoeostasis.
Reducing Wnt ligand secretion led to a reduced number of
ISCs. If the ISCs carry a mutation in Apc, this decreased cell
competition results in faster population of the crypt by the Apc-
deﬁcient cells and hence accelerated tumorigenesis. Importantly
we see this across multiple different models of Apc loss (Lgr5
mediated deletion of both copies of Apc, and in VilCreER Apcﬂ/+
followed by loss of heterozygosity of the remaining wild-type
allele).
Our work raises an important technical consideration for
previous work looking at selective advantages/disadvantages of
particular alleles using the tdTom reporter. It may be that the
problem of overestimating the recombination efﬁciency is unique
to the Apc580S allele in combination with the R26-LSL-tdTom
allele. In this case, a total of three alleles need to be recombined to
turn on the reporter and achieve homozygous deletion of Apc.
However previous studies have shown discordant recombination
even if two reporter alleles are at the R26 locus16.
It should be noted that, as the Apc580S mouse is a hypomorph,
any changes in previously published work might be down to the
reduced expression of Apc compared to wild-type mice. More-
over, it raises important questions on work suggesting that
Apc loss does not lead to Wnt signalling activation and there
may be existence of occult Apc-deﬁcient crypts. Using the
RNA in situ probes, we do not observe deleted Apc crypts that
have not accumulated nuclear β-catenin and the associated
phenotypes.
The low efﬁciency of Apc loss in 3 mg tamoxifen-treated mice
is also reﬂected in the distribution of adenomas in these models.
However, we believe the most likely way to explain this pheno-
type is via differences in the Wnt gradient along the small
intestine and maybe partly due to different recombination efﬁ-
ciencies. Previous studies have suggested that the mouse proximal
small intestine may have a higher levels of basal Wnt signalling,
making it suboptimal for tumorigenesis with certain Apc muta-
tions, e.g. Apc Min/+(ref. 23). Here by using a Wnt inhibitor we
make the proximal intestinal more permissive for tumorigenesis
following Apc loss, again reinforcing the 'just right' hypothesis of
Wnt signalling.
A recent study found a similar role in limiting the
number of ISCs by blocking the R-spondin ligands. Inhibition of
R-spondins also led to disappearance of Lgr5+ ISCs, despite
normal homoeostasis. Similarly the authors observed a shorter
time to monoclonality, suggesting that reduction of Wnt ligands
or R-spondin can lead to the observed stem cell dynamic
changes13.
One question that arises from our study is why we observed
only a minor impact in homoeostasis in long-term porcupine
inhibitor-treated intestines. Our current hypothesis is that even
reduced Wnt signalling at the base of the crypt is sufﬁcient to
maintain epithelial homoeostasis, despite a reduction in the
number of ISCs. A recent study in intestinal organoids may also
support this paradigm. Here, Wnt3 did not freely diffuse but is
bound to the membrane and spreads passively due to cell divi-
sion24. In this case, we could imagine that a reduction of the Wnt
ligands bound to the membrane are sufﬁcient for the ISCs in the
centre of the niche, but since proliferation is not changed the
cells further away receive less Wnt ligands and are therefore
lost from the ISC pool. Therefore, further reduction of
Wnt signalling with higher doses of Porcupine inhibitor or low-
ering β-catenin expression can then affect the stem cells in the
centre as well, leading to their differentiation and loss of the
intestinal crypts.
Our work has also shown that the increase in the number of
crypts per circumference after MAPK pathway activation is Wnt
ligand dependent. Here, we were able to stop the additional
crypt ﬁssion by treatment with the Porcupine inhibitor (Supple-
mentary Figure 3). Therefore, Wnt inhibition may prevent
tumours developing from more serrated routes, which are often
associated with a lack of APC mutation and carry BRAF or KRAS
mutations.
Methods
Mice and treatment. All experiments were performed following the UK Home
Ofﬁce guidelines. All mice were maintained under non-barrier conditions and
given a standard diet and water ad libitum. The following mouse strains were used:
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VilCreER (ref. 25), Lgr5CreER (ref. 26), AhCreER (ref. 27), R26R-LSL-tdTomato
(tdTomﬂ) (ref. 28), Apcﬂ (ref. 29), Catnblox(ex3) (ref. 30), BrafV600 E (ref. 31), PTENf l
(ref. 32). The Lgr5CreER Apcﬂ/ﬂ and VilCreER Apcﬂ/+ mice were on a C57/B6
background (backcrossed ≥10 generations). The Porcupine inhibitor LGK974 (also
referred to as WNT974) was administered in a concentration of 5 mg/kg BID (oral)
in a vehicle of 0.5% Tween-80/0.5% methylcellulose. AhCreER mice were induced
with 1 mg β-naphthoﬂavone (Sigma) and 0.15 mg tamoxifen (Sigma) IP. VilCreER
and Lgr5CreER mice were induced with tamoxifen (Sigma) IP at the concentrations
indicated throughout the manuscript.
Immunohistochemistry/RNA in situ hybridisation. Standard immunohis-
tochemistry techniques were used throughout this study. The following primary
antibodies were used: BrdU (1/200, #347580, BD Biosciences), β-catenin (1/50
#610154, BD Biosciences), lysozyme (1/200, DAKO #A0099), RFP (1/200, Rock-
land #600-401-379). RNA in situ hybridisation (RNAscope) was performed
according to the manufacturer’s protocol (ACD RNAscope 2.0 High
Deﬁnition–Brown) for Lgr5 and Olfm4. BaseScope (also ACD) Apc EX14 #701641
(detects wild-type APC exon 14) and Apc E14E16 #703011 (detects ﬂoxed APC)
were used according to the manufacturer’s instructions.
Staining for nuclear β-catenin and RNA in situ hybridisation was performed on
tissue samples ﬁxed at 4 °C for less than 24 h in 10% formalin prior to processing.
RNAseq. Whole tissue from the small intestine was used for RNA puriﬁcation. The
RNA Integrity was analysed with a NanoChip (Agilent RNA 6000 Nanokit #5067-
1511). A total of 2 µg of RNA per sample was puriﬁed via Poly-A selection.
The count matrix returned from the SAM tools was analysed with the R-package
DESeq33 which returned differentially expressed genes with threshold of
the adjusted p-value (padj) of <0.1. A heatmap of the signiﬁcantly
deregulated genes was created based on the shape of gene expression by Pearson
correlation.
In vivo imaging. The in vivo imaging was performed as previously described1.
Lgr5CreER R26R-LSL-tdTomato Mice (tdTomﬂ) were induced with 0.05 mg
tamoxifen. After placing the abdominal imaging window (AIW), mice were
kept under anaesthesia and were imaged once a day. After the imaging sessions
the mice were allowed to wake up to maintain their body temperature. After
imaging, acquired z-stacks were corrected for z and xy shifts using a custom-
designed VisualBasic software program and further processed and analysed
using basic functions in ImageJ software (linear contrasting, blurring, median
ﬁltering).
Clonal counting. Lgr5CreER tdTomﬂ mice were induced with 0.15 mg tamoxifen
(IP) as previously described14. AhCreER tdTomﬂ mice were induced with 1 mg β-
naphthoﬂavone and 0.15 mg tamoxifen (IP). The small intestines of mice
were sampled at different time points and ﬁxed with freshly prepared 4%
paraformaldehyde for 3 h at room temperature. The small intestinal tissue
was then incubated with DAPI (10ug/ml) in 0.1% PBS-Tween20 (PBS-T) over-
night. Whole mount sections were then imaged using a Zeiss 710 confocal
microscope.
Regeneration. C57/B6 mice were irradiated with 10 Gy and treated with LGK974/
WNT974 (Porcupine inhibitor) or vehicle 6 h after irradiation. The mice were
sampled 72 h after irradiation. The number of regenerating crypts per cir-
cumference (10 per mouse) of the small intestine was scored and the average of
regenerating crypts per mouse represented in the graph.
Statistics. All data were analysed with R34 and the use of the ggplot2 package35
and the survival package36.
Data availability. Microarray data that support the ﬁndings of this study have
been deposited in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under
accession number E-MTAB-4178.
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